InterveXion Therapeutics' Incubator/Accelerator Round

InterveXion Therapeutics raised a round of funding on , . Investors include UAMS Arkansas BioVentures.

InterveXion Therapeutics is a drug discovery and development company focused on antibody-based therapies for treating human disease. The company are developing monoclonal antibodies to treat substance…

Articles about InterveXion Therapeutics' Incubator/Accelerator Round: